- Report
- March 2024
- 132 Pages
Global
From €900EUR$950USD£752GBP
- Report
- March 2024
- 30 Pages
Brazil
From €825EUR$932USD£713GBP
- Report
- September 2021
- 26 Pages
Russia
From €825EUR$932USD£713GBP
The Decongestant market is a subset of the Cough and Cold Drugs market, which includes medications used to treat symptoms of the common cold, such as nasal congestion, sinus pressure, and chest congestion. Decongestants are typically available in both over-the-counter (OTC) and prescription forms, and are often used in combination with other medications to treat cold and flu symptoms. Decongestants work by narrowing the blood vessels in the nasal passages, reducing inflammation and allowing for easier breathing.
Common OTC decongestants include pseudoephedrine, phenylephrine, and oxymetazoline. Prescription decongestants include ephedrine, phenylephrine, and phenylpropanolamine. Decongestants are also available in combination with other medications, such as antihistamines, expectorants, and cough suppressants.
Some companies in the Decongestant market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more